Journal profile · Pharmacology & Pharmacy
Drug Metabolism and Disposition
ISSN 0090-9556 · eISSN 1521-009X · American Society for Pharmacology and Experimental Therapeutics · UNITED STATES · Monthly · Founded 1973
Drug Metabolism and Disposition: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 3.52; hybrid open access; APC about USD 3,500; median 93 days to acceptance (108 articles, last 24 months); community-reported acceptance: fairly hard; 193 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Drug Metabolism and Disposition is published by American Society for Pharmacology and Experimental Therapeutics and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Pharmacogenetics and Drug Metabolism, Drug Transport and Resistance Mechanisms and Pharmacological Effects and Toxicity Studies, together about 48.1% of its articles. Its main subfields are Pharmacology. (generated from OpenAlex topic counts and CAS ranking data)
Drug Metabolism and Disposition DMD presents important research in pharmacology and toxicology and is a valuable resource in drug design, drug metabolism, drug transport, expression of drug metabolizing enzymes and transporters, and regulation of drug metabolizing enzyme and transporter gene expression. More ASPET The American Society for Pharmacology and Experimental Therapeutics (ASPET) is a 4,000 member scientific society whose members conduct basic and clinical pharmacological research and work for academia, government, large pharmaceutical companies, small biotech companies, and non-profit organizations. ASPET members work in a variety of different fields and include neuroscientists, toxicologists, chemical biologists, pharmacists, cardiovascular scientists, and many more. Though very diverse, our members have a common bond through their membership in ASPET. Our members' research efforts help develop new medicines and therapeutic agents to fight existing and emerging diseases.
From the journal's Aims & Scope
Research area (LetPub): Pharmacology & Pharmacy
Editor-in-chief Xinxin DingPublisher website
Editorial board by country: 9 in mainland China (about 8%); most named United States 73, Mainland China 9, Canada 9, Japan 7, United Kingdom 3 (113 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pharmacogenetics and Drug MetabolismPharmacology, Toxicology and Pharmaceutics24.2%
- Drug Transport and Resistance MechanismsMedicine17.8%
- Pharmacological Effects and Toxicity StudiesMedicine6.1%
- Drug-Induced Hepatotoxicity and ProtectionPharmacology, Toxicology and Pharmaceutics4.5%
- Eicosanoids and Hypertension PharmacologyBiochemistry, Genetics and Molecular Biology4.4%
- Metabolism and Genetic DisordersBiochemistry, Genetics and Molecular Biology3.8%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance3.7%
- Analytical Chemistry and ChromatographyChemistry3.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Pharmacology & Pharmacy | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.52LetPub ·
- Impact factor (publisher)
- 3.6Publisher website ·
- CiteScore 2026-06
- 6.8LetPub ·
- CiteScore (publisher)
- 6.8Publisher website ·
- SJR 2026-06
- 1.05LetPub ·
- SNIP 2026-06
- 1.14LetPub ·
- h-index
- 161LetPub ·
- h-index
- 207OpenAlex ·
- i10-index
- 6,986OpenAlex ·
- 2-year mean citedness
- 3.13OpenAlex ·
- Self-citation rate
- 19.4%LetPub ·
- Share of gold OA articles
- 16.83%LetPub ·
Volume
- Articles per year
- 262LetPub ·
Articles by year OpenAlex count · 10,526 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 183 | 74 | 44 |
| 2025 | 193 | 104 | 527 |
| 2024 | 173 | 115 | 1,146 |
| 2023 | 180 | 111 | 1,759 |
| 2022 | 168 | 130 | 2,402 |
| 2021 | 145 | 127 | 3,024 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
93 daysMedian, submission to acceptance · P25–P75 68 days – 129 days
- Acceptance to online
- median 6 days (108 articles)
- Submission to online
- median 99 days
- Sample
- 108 articles with submission and acceptance dates (424 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 3 monthsLetPub ·
- Average acceptance (community reports)
- Fairly hardLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,500 / EUR 3,270 / GBP 2,800 / JPY 434,110 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- American Society for Pharmacology and Experimental Therapeutics
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- Founded
- 1973
- ISSN
- 0090-9556
- Electronic ISSN
- 1521-009X
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Drug Metabolism and Disposition
What CAS zone is Drug Metabolism and Disposition in?
In the 2025 upgraded edition of the CAS Journal Ranking, Drug Metabolism and Disposition is in Zone 2 of Medicine, and in Zone 2 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Drug Metabolism and Disposition?
The latest impact factor listed by LetPub is 3.52; CiteScore 6.8, h-index 207.
How long does peer review take at Drug Metabolism and Disposition?
Based on the dates recorded on 108 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 93 days (interquartile range 68–129 days); authors report an average review time of about 3 months; the community-reported acceptance is “Fairly hard”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Drug Metabolism and Disposition based?
Of the 113 board members whose country the journal's board page names, 9 (about 8%) are in mainland China; the countries named most often are United States (73), Mainland China (9) and Canada (9). Counted from the institutions listed on the board page; for reference only.
Which databases index Drug Metabolism and Disposition?
According to LetPub and DOAJ records, Drug Metabolism and Disposition is indexed in SCIE and Scopus.
Is Drug Metabolism and Disposition open access, and what is the APC?
Drug Metabolism and Disposition is a hybrid journal. For open-access publication: APC about USD 3,500.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .